News + Filings Holdings
|
Rhenman & Partners Asset Management AB
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 123,000 | -265,000 | 3,113,130,000 | 3,104,474,000 | $25,310.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 388,000 | -62,000 | 8,656,000 | 2,437,000 | $22.31 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 450,000 | 251,642 | 6,219,000 | 2,351,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 198,358 | 198,358 | 3,868,000 | 3,868,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 0 | -320,000 | 0 | -8,915,000 | |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 320,000 | 50,000 | 8,915,000 | 912,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 270,000 | 50,000 | 8,003,000 | 1,768,000 | $29.64 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 220,000 | 0 | 6,235,000 | 704,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 220,000 | 0 | 5,531,000 | 159,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 220,000 | 0 | 5,372,000 | 2,116,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 220,000 | -30,000 | 3,256,000 | -802,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 250,000 | 76,083 | 4,058,000 | 1,797,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 173,917 | -19,264 | 2,261,000 | -245,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 193,181 | 0 | 2,506,000 | -539,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 193,181 | 0 | 3,045,000 | -844,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 193,181 | -10,000 | 3,889,000 | -1,160,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 203,181 | 0 | 5,049,000 | -528,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 203,181 | 0 | 5,577,000 | -681,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 203,181 | 20,601 | 6,258,000 | -269,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 182,580 | -63,820 | 6,527,000 | -261,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 246,400 | 26,400 | 6,788,000 | 980,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 220,000 | 10,000 | 5,808,000 | 1,440,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 210,000 | 0 | 4,368,000 | 21,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 210,000 | 0 | 4,347,000 | -3,399,753,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 210,000 | 40,000 | 3,404,100,000 | 3,401,132,000 | $16,210.00 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 170,000 | -3,000 | 2,968,000 | -2,942,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 173,000 | 173,000 | 5,910,000 | 5,910,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 148,000 | -24,000 | 4,404,000 | -1,097,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 172,000 | -64,000 | 5,501,000 | 609,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 236,000 | 236,000 | 4,892,000 | 4,892,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 126,574 | 126,574 | 2,144,000 | 2,144,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 105,255 | 23,255 | 2,035,000 | -753,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 82,000 | 82,000 | 2,788,000 | 2,788,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 49,135 | 49,135 | 1,548,000 | 1,548,000 | $31.51 |
| << Prev Next >> |
|